Accuray Receives FDA 510(k) Clearance for New CyberKnife® M6™ Series, Merging Multileaf Collimation with Non-Isocentric Robotic Delivery (via PR Newswire)
SUNNYVALE, Calif., Nov. 1, 2012 /PRNewswire/ — Accuray Incorporated (Nasdaq: ARAY), the premier radiation oncology company, today announced that the company received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its new CyberKnife® M6™ Series. The CyberKnife M6 Series features…
